NeoGenomics (NASDAQ:NEO) reported Q1 2018 earnings this Morning, coming in at $0.04 per share, beating Wall Street’s estimates of $0.03 per Share. Revenue for the quarter came in at $63.40 million beating analyst estimates of $62.31 million Recent Insider Trading for NeoGenomics (NASDAQ:NEO)
- On 7/27/2017 Alison L Hannah, Director, bought 20,000 with an average share price of $9.19 per share and the total transaction amounting to $183,800.00.
- On 6/22/2017 Jennifer Balliet, VP, sold 10,723 with an average share price of $8.49 per share and the total transaction amounting to $91,038.27.
- On 6/5/2017 Steven A Ross, Insider, sold 70,833 with an average share price of $7.76 per share and the total transaction amounting to $549,664.08.
- On 5/26/2017 Jennifer Balliet, VP, sold 3,334 with an average share price of $7.50 per share and the total transaction amounting to $25,005.00.
- On 3/20/2017 Steven G Brodie, Insider, sold 50,000 with an average share price of $7.93 per share and the total transaction amounting to $396,500.00.
- On 9/23/2016 Maher Albitar, Insider, sold 2,800 with an average share price of $8.40 per share and the total transaction amounting to $23,520.00.
Dividend History for NeoGenomics (NASDAQ:NEO)
Recent Trading for NeoGenomics (NASDAQ:NEO) Shares of NeoGenomics closed the previous trading session at 9.67 up +0.09 0.94% with 9.670000076293945 shares trading hands.